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ABSTRACT
Objective: The present investigation aimed at the screening of pharmaceutically potential antimicrobial metabolite isolated from marine 
Micromonospora sp. to combat the multidrug‑resistant bacteria.
Materials and Methods: The Marine sediments were randomly collected for the isolation of Micromonospora sp., from Gulf of Mannar, East Coastal 
Region, located at Kayalpatnam, Tuticorin district, Tamil Nadu, India. The Micromonospora sp. was cultivated by serial dilution and crowed plating 
method on actinomycetes isolation agar. The isolated colonies were identified by morphological, cultural, and biochemical methods. The antibacterial 
study of Micromonospora sp. was performed on Mueller‑Hinton agar medium against multidrug‑resistant bacteria isolated from urinary tract infection. 
The antibacterial compound was separated and characterized by Fourier‑transform infrared (FT‑IR) and nuclear magnetic resonance (NMR) spectrum.
Results: Based on the morphological, cultural, and biochemical studies, the isolated colonies were found to be the genera of Micromonospora. Among 
Micromonospora genera, Micromonospora marina KPMS1 strain showed potent antibacterial activity against multidrug‑resistant Escherichia coli, 
Pseudomonas aeruginosa, and Enterococcus faecalis. The FT‑IR and NMR studies showed the structural elucidation of active compounds derived from 
M. marina KPMS1. The 16S rRNA sequences of M. marina KPMS1 (MH036351) strain were blasted and deposited in the GenBank of National Center 
for Biotechnology Information.
Conclusion: The results of the study were concluded that microbial compounds are the promising sources of nearly all of the antibiotics produced 
by marine Micromonospora sp. The detection of new biological compounds was considered to represent a novel species of the genus Micromonospora 
which have been used for clinical treatment against multidrug‑resistant bacteria and were pharmaceutically important.
Keywords: Biochemical studies, 16S rRNA sequences, Antimicrobial, Antibiotics, Multidrug‑resistant bacteria.
INTRODUCTION
The Actinobacteria are one of the plentiful sources of novel biological 
metabolites. Among Actinobacteria, the genera of Micromonospora have 
been accommodated as a reservoir of antimicrobial agent and novel 
secondary metabolite producer next to the Streptomyces genera [1]. The 
genus Micromonospora has been documented as aerobic, spore‑forming 
Gram‑positive, filamentous bacteria which are characterized by aerial 
and substrate mycelia. Micromonospora sp. produced single non‑motile 
spores on substrate mycelia. Many species of the genus Micromonospora 
have been isolated from diverse environments. More than 50% of 
bioactive compounds were derived from different regions in soil produced 
by soil‑inhabiting genera Micromonospora [2]. The few are found in root 
nodules and sea sand [3]. Currently, Micromonospora sp. was isolated 
from marine sponge, marine water, and it sediments [4]. Not only soil 
region, the marine water and its sediments also harbor microbial rich 
environment which have abundant microbial communities ranging 
from 106 to 109 CFU/g [5]. The potential source of bioactive metabolites 
was produced by Micromonospora strains which are pharmaceutically 
important. Among these compounds, aminoglycoside group of antibiotics 
is predominant followed by macrolide antibiotics [6]. Among 23,000 
bioactive compounds, more than 740 bioactive metabolites isolated from 
family Micromonosporaceae such as gentamicin, neomycin, sagamicin, 
mutamicin, verdamicin, rifamycins, sisomicin, erythromycin B, and 
fortimicins have been used for clinical treatment [7]. The marine 
Micromonospora not only have several new species but also have 
number of novel secondary metabolites that have different mechanisms 
of action in worldwide [8]. The present study was aimed to identify the 
antimicrobial compound isolated from marine Micromonospora sp. and 
its antibacterial activity against the multidrug‑resistant bacteria.
MATERIALS AND METHODS
Materials
All chemicals were purchased from Merck (Germany), HiMedia (India), 
or Thermo Fisher Scientific Pvt., Ltd. (India) unless otherwise indicated. 
All buffers and reagents used in this study were prepared in distilled 
water.
Sample collection and cultivation
The marine sediment samples were collected and air dried at room 
temperature. 1 g marine sediment was suspended in 9 ml of distilled 
water and serially diluted upto 10‑9 dilution. 1 ml of each dilution series 
was inoculated into Actinomycete Isolation Agar (AIA) supplemented 
with cycloheximide (50 µg/ml) and incubated at 28°C for 2–3 weeks. 
The selected colonies were subcultured and maintained on AIA with 
25% v/v glycerol at 4°C [9].
Morphological identification
Gram reaction
Most of the actinobacteria can be differentiated by their gram reaction 
due to differences in their cell wall structure. In this technique, the cell 
smear was mad and flooded with complex chemical stains and focused 
on the microscope under × 100 magnification.
Slide culture analysis
The morphology of spore based on the aerial and substrate mycelium 
was observed by slide culture method. The agar blocks were prepared 
using AIA. The selected colonies were inoculated in every corner of the 
agar blocks. The setup was kept in moist chamber under incubation at 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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28°C for 1 week. After incubation, the aerial and substrate mycelia were 
examined under high power magnification using Sudan black stain. The 
spore morphology was examined under bright‑field microscope using 
0.1% crystal violet stain along with a drop of culture.
Biochemical reaction
The biochemical and physiological properties were identified by 
indole production test, methyl red test, Voges–Proskauer test, citrate 
utilization test, catalase test, oxidase test, starch hydrolysis test, urea 
hydrolysis test, and utilization of triple sugar iron agar test [10].
L‑asparaginase production
L‑asparaginase production was carried out by submerged fermentation 
on minimal media broth incorporated with phenol red indicator [11]. 
The selected colonies were inoculated and incubated in a rotary shaker 
at 28°C for 24 h. At the end of the incubation, the crude enzyme was 
prepared by centrifugation at 10,000 rpm for 20 min. The cell‑free 
supernatant was separated by centrifuging at 10,000 rpm for 20 min.
Antibacterial studies
For fermentation studies, the selected strains were inoculated on ISP 
4 medium and incubated under 150 rpm in a rotary shaker at 28°C 
for 2 weeks. After incubation, the growth was analyzed by optimal 
density at 600 nm, and the dry weight of the mycelium was measured 
and correlated with the growth of the isolate. The cell‑free supernatant 
was collected by centrifugation at 10,000 rpm from fermented broth 
and filtrated by nitrocellulose filter paper. The cell‑free culture filtrate 
was mixed with an equal amount of ethyl acetate and kept under 
200 rpm overnight. The solvent phase was collected and tested against 
multidrug‑resistant bacteria.
Preliminary antibacterial activity was performed on Mueller‑Hinton 
agar by agar well diffusion method. The 100 µl of crude ethyl acetate 
extract of selected active strain was tested against multidrug‑resistant 
bacteria and incubated at 37°C for 24 h. After incubation, all plates were 
examined for the zone of inhibition around the wells.
Biological activity
The purification of antimicrobial compounds was performed by 
thin‑layer chromatography (TLC) plate [12]. The crude extract of 
selected strain was applied on marked spot using a capillary tube 
and the spots were dried. The solvent of n‑butanol: ethyl acetate: 
water (9:9:1) was prepared, and the TLC plate was vertically placed into 
solvent chamber. The distance of solvent moved up to 2 cm below the 
top of TLC plate and the plate was removed from solvent chamber. The 
fractions were detected under ultraviolet chamber, and the Rf values 
were recorded:
Rf = Distance of solute/distance of solvent
TLC fractions were separated and 100 µl of 5 mg/ml concentration of 
selected fraction was loaded on sterile disc. The multidrug‑resistant 
bacteria Escherichia coli, Pseudomonas aeruginosa, and Enterococcus 
faecalis were inoculated over the Mueller‑Hinton agar plates. Standard 
drug cefotaxime (10 mg) was placed on the agar plates and incubated 
at 37°C for 24 h. After incubation, the zone of inhibition was measured.
The minimal inhibitory concentration (MIC) was performed on 
Mueller‑Hinton broth by tube dilution method. In each of the test tubes, 
2 ml of Mueller‑Hinton broth was added. Various concentrations of 
standard antibiotic and active compound were prepared by dilution 
of × 2 concentration of drug. The concentration of diluted antibiotics 
and sample was 100, 50, 25, 12.5, 6.25, 3.12, 1.56, and 0.78 µg/ml. 
A tube without drug was negative control and uninoculated tube served 
as sterility control. After dilution, test organism was inoculated into all 
tubes and incubated for 24 h. After incubation, the lowest concentration 
of antibiotics and its growth inhibition was recorded by the addition of 
resazurin indicator [13].
Characterization of active compound Fourier‑transform 
infrared (FT‑IR) and nuclear magnetic resonance (NMR) spectrum
The active compound of Micromonospora was subjected to FT‑IR 
spectral analysis. The FT‑IR spectrum ranges between 4000 and 
400 cm  −  1 with the resolution of 0.9 cm  −  1. The FT‑IR spectrum was 
recorded with 95% methanol. The resulting FT‑IR spectral pattern 
was analyzed and confirmed the presence of functional groups in the 
absorption peaks which were compared with known signatures of 
identified standard.
The NMR (C13 and H1NMR) spectroscopy was used to determine the 
chemical structural properties of active compound derived from 
Micromonospora strain. The NMR experiment was conducted on a 
400 MHz JOEL NMR spectrophotometer at the National Institute of 
Technology, Tiruchirappalli, Tamil Nadu, India.
Molecular characterization and phylogenetic tree analysis
The chromosomal DNA isolation was performed by the exponential 
growth of Micromonospora on actinomyceye isolation broth. The cell 
pellet was collected and resuspended in 567 µl of TE buffer, 30 µl of 10% 
SDS, 3 µl of 20 mg/ml proteinase K, and incubated at 37°C. Addition of 
100 µl of 5 M NaCl and 80 µl of CTAB‑NaCl solution was mixed well 
on a vortex mixer until the cell suspension became translucent and 
incubated at 65°C for 10 min. An equal volume of chloroform and 
isoamyl alcohol was added and centrifuged at 5000 rpm for 5 min. 
The aqueous phase was aspirated and mixed with an equal volume 
of phenol, chloroform, and isoamyl alcohol which were centrifuged 
for 5 min. The aqueous phase was collected and transferred to 1.5 ml 
microfuge tube. Subsequently, 0.6 volume of isopropanol and 100 µl 
of 3 M sodium acetate were added. The precipitate was collected by 
centrifugation and washed with 70% ethanol, dried, and dissolved in 
100 µl of TE buffer.
Polymerase chain reaction (PCR) amplification of 16S rRNA gene sequence 
was carried out by two primers for matching most of known eubacteria 
order. The amplification of 16S rRNA gene sequence was carried out using 
the forward primer F243 (5ꞌ‑GGATGAGCCCGCGGCCTA‑3ꞌ) and reverse 
primer R513GC (5ꞌ‑CGGCCGCGGCTGCTGGCACGTA‑3ꞌ) with an activation 
temperature of 95°C for 5 min, followed by denaturation of 94°C for 1 
min, the primer annealing at 52°C for 0.5 min, elongation at 72°C for 2 
min and the final elongation temperature at 72°C for 10 min. The 5 µl of 
the PCR product was loaded on 1.2% agarose gel in × 1 Tris‑borate‑EDTA 
buffer and stained with ethidium bromide 0.5 µl/ml. The PCR product 
was precipitated by polyethylene Glycol (PEG)‑NaCl (20% PEG in 
2.5 M NaCl) precipitation at 37°C for 30 min. The reaction mixture 
was centrifuged at 12,000 rpm for 30 min at room temperature. The 
supernatant was discarded and the pellet was washed twice with 70% 
ethanol. The forward and reverse DNA sequencing reaction of PCR 
amplicon was carried out using BDT v 3.1 cycle sequencing kit on ABI 
3730 × l genetic analyzer.
The reference sequence required for comparison was downloaded 
from the GenBank using BLASTN sequence based retrieval system 
from GenBank (URL http://www.ncbi.nlm.nih.g) using our sequence 
as the query. Based on the sequenced data, the phylogenetic tree was 
constructed using the bioinformatics tool MEGA 5.05 for aligning the 
sequences by neighbor‑joining method. The 16SrRNA sequences for the 
Micromonospora have been deposited in GenBank using sequin (http://
www.ncbi.nlm.nib.gov/genebank)
RESULTS AND DISCUSSION
Collection site and morphological studies
The collection site of marine sediments was located at Gulf of Mannar, 
East Coastal Region, Kayalpatnam, Tuticorin district, Tamil Nadu, India. 
East Coastal Region is bestowed with rich natural flora which has been 
considered as a potential source of marine Micromonospora was studied 
for its bioactivity. The physiological and climatic condition of marine 
sediment region of this site has resulted in diverse type bio‑organism 
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contributing to enrich the biological diversity. The collection marine 
sediments were done randomly. The sediments were taken 0–5 cm 
depth. The isolation of Micromonospora was performed using serial 
dilution and plating method by AIA supplemented with cycloheximide. 
The specific antibiotics were added into the isolation media which is 
used to suppress the growth of other actinobacteria [14]. The growths 
of marine Micromonospora colonies were recognized by their mycelium 
formation. All the Micromonospora colonies were subcultured on AIA 
slants. The marine sediments were screened and the Micromonospora 
colonies were isolated, and the numbers of colonies were calculated 
as 6 × 106 CFU/g. All the isolates were identified at their generic level 
based on the colony morphology and microscopic morphology. The 
ecological niche of marine sediments may have the valuable source for 
the isolation of novel Micromonospora with the potential to produce 
new secondary metabolites [15].
The identification of strains was observed by both morphological and 
cultural characteristics, revealing that most of the isolates were showed 
the nature of color such as greenish gray, dull white, whitish ash, dark 
gray, brownish yellow, and whitish gray on AIA. The colonies were 
elevated 3–4 mm in diameter, initially had a smooth appearance, and later 
developed the rough colonies. The aerial mycelium absent in all isolates 
except KPMS10 developed a weft of aerial mycelium which is granular 
or powdery in nature. All isolates produced single and non‑motile spore 
on substrate mycelium. The pigments were raised in four isolates except 
KPMS17and KPMS19. Two isolates KPMS1 and KPMS10 were produced 
melanoid pigments [Table 1]. All the Micromonospora sp. showed 
septate hyphae with monospore on substrate mycelium by slide culture 
methods. The present study revealed that all Micromonospora isolates 
were found to be Gram‑positive cell wall. The Micromonospora are 
currently updated with spore‑forming Gram‑positive nature of bacteria 
that form extensive branching of substrate mycelia [16].
Carbohydrate utilization
The Four isolates were found to be positive for triple sugar iron test 
with acid butt and alkaline slant. Only two strains of KPMS 9 and 
KPMS 19 produced acid butt and acid slant with gas production. The 
potent strain was tentatively identified by the utilization of different 
carbohydrate source that they belong to distinct taxonomic groups 
which have been well documented [17].
Biochemical screening
The biochemical characteristics of Micromonospora strains showed 
positive results on indole and urease. Four isolates showed methyl red 
except KPMS10 and KPMS17. Two isolates KPMS10 and KPMS17 were 
positive in Voges–Proskauer. All the strains were negative on citrate 
utilization test. Among six strains, three were catalase and oxidase 
positive and two were starch positive [Table 2]. The Micromonospora 
genera were further identified using physiological and biochemical 
tests. This finding gives an initial recognition as novel taxa isolated 
from marine sediments [18]. The ability of starch, casein, and urease 
hydrolysis is immense importance for both practical and taxonomical 
approaches considered for the proper identification of Micromonospora 
genera which has been documented [19].
Among six isolates, KPMS1 and KPMS10 showed L‑asparaginase 
activity on minimal broth medium incorporated with phenol red 
indicator, glucose, and yeast extract as carbon and nitrogen substrates. 
After incubation, the medium turned pink color due to the production 
of ammonia which indicated the positive result of L‑asparaginase 
production. The marine actinobacteria are serving as a good source of 
L‑asparaginase enzyme and used as a chemotherapeutic agent [20].
Antibacterial studies
The antibacterial screening was carried out for Micromonospora 
strains on ISP 4 medium using ethyl acetate extract at a concentration 
of 2:1 (v/v). The quantity of concentrated product was calculated 
by the initial weight of watch glass (g) subtracted by final weight of 
watch glass (g) equal to concentrated component weight (g). The 
concentrated components were redissolved in distilled water and 
analyzed for secondary screening process. In screening process, all 
Micromonospora strains were tested against multidrug‑resistant 
bacteria E. coli, P. aeruginosa, and E. faecalis isolated from urinary tract 
infection (UTI) infection.
In preliminary screening, Micromonospora marina KPMS1 was highly 
sensitive to multidrug‑resistant bacteria isolated from UTI. The highest 
inhibition showed in Klebsiella pneumoniae (18 ± 0.04 mm) with a relative 
zone of inhibition of 88%, P. aeruginosa (17 ± 0.01 mm) with relative 
zone of inhibition of 76%, and Enterococcus faecium (16 ± 0.08 mm) 
with relative zone of inhibition of 80%. The comparison was done by 
standard antibiotic cefotaxime, and the percentage of relative inhibitory 
zone was found to be ranged between 76% and 88% [Table 3].
The bioactive compound extracted from M. marina KPMS1 and 
concentrated with ethyl acetate was subjected to TLC analysis using 
three mobiles phase, namely chloroform: benzene: methanol: ethyl 
acetate (4:2:2:1), chloroform: methanol: ethyl acetate (2:1:1), and 
chloroform: methanol: ethyl acetate (2:1:1). After airdrying, the plates 
were visualized with iodine vapors. Among three mobile phases, the 
plate developed with solvent system 3 gave the best separation. A total 
of three different spots were obtained from M. marina KPMS1 sample 
with Rf values of 0.76, 0.62, 0.51, and 0.42.
Table 1: Identification of Micromonospora isolates
Isolated 
strains
Mycelium Color of mycelium Pigmentation Carbohydrate utilization Melanoid pigments
KPMS 1 SM Greenish gray Yellowish green Acid butt and alkaline slant Positive
KPMS 9 SM Dull white Diffusible yellowish brown Acid butt, acid slant with gas production Negative
KPMS 10 AM/SM Whitish ash Diffusible red wine Acid butt and alkaline slant Positive
KPMS 13 SM Dark gray Pale yellow Acid butt and alkaline slant Negative
KPMS 17 SM Brownish yellow ‑ Acid butt and alkaline slant negative
KPMS 19 SM Whitish gray ‑ Acid butt, acid slant with gas production negative
Table 2: Biochemical properties of Micromonospora isolates
Isolated strain Indole MR VP Citrate Catalase Oxidase Starch Urease
KPMS 1 + + ‑ ‑ + + + +
KPMS 9 + + ‑ ‑ ‑ ‑ ‑ +
KPMS 10 + ‑ + ‑ + + ‑ +
KPMS 13 + + ‑ ‑ ‑ + + +
KPMS17 + ‑ + ‑ ‑ ‑ ‑ +
KPMS 19 + + ‑ ‑ + ‑ ‑ +
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In secondary antibacterial screening of M. marina KPMS1, the fraction 
one showed highly sensitive to E. coli 18 ± 0.07 mm with 87%, 
P. aeruginosa 17 ± 0.06 mm with 77%, and E. faecalis 17 ± 0.05 mm with 
81% of the relative zone of inhibition. As compared to standard antibiotic 
cefotaxime, the percentage of the relative inhibitory zone was found to 
range between 77% and 87% [Table 4]. The results clearly demonstrate 
that a Gram‑negative bacterium E. coli was highly susceptible to the 
tested crude extracts compared to Gram‑positive E. faecalis bacteria. 
The M. marina KPMS1 showed significant antibacterial activity against 
multidrug‑resistant Gram‑negative and Gram‑positive bacteria and 
it proved a promising antibacterial strains. The screening of the 
antimicrobial metabolites derived from Micromonospora isolates 
is often encountered and showed antibacterial activity against 
multidrug‑resistant bacteria isolated from human beings [21]. The 
unusual antibiotic profile exhibited from Micromonospora strains was 
isolated from marine sediment and its biopotential activity against 
multidrug‑resistant bacterial pathogens [13].
The active fraction showed a dose‑dependent antimicrobial activity 
against the pathogen tested with zones of inhibition ranging from 17 
and 19 mm in size at 2 mg/ml. The minimal concentration to inhibit the 
tested bacterial pathogen was determined by microdilution method, 
indicating that the minimum inhibitory concentration of active fraction 
was 6.2–12.5 µg/ml. This could be either due to the low concentration 
of the active inhibitory molecules or the presence of molecules with 
high inhibition constant. The MIC varied among the tested compounds 
against E. coli. These results were similar with the other report [22].
Detection of bioactive compound
In chemical screening, the crude potential fractions of M. marina KPMS1 
recovered after fermentation were purified by TLC and identified with 
FT‑IR and NMR analysis [23]. The FT‑IR spectral analysis was carried out 
to determine the functional groups present in the M. marina KPMS1. The 
active fraction of spectra was scanned in the 4000–400 cm − 1 and plotted 
as intensity and wave number. The absorption bands were exhibited at 
3465.78 cm − 1–1095.33 cm − 1 (Fig. 1). A broad stretching in the region 
3465.78  cm  −  1  (O–H  stretching),  2929.32  cm  −  1  (C‑H  stretching), 
2361.93 cm − 1  (C‑N stretching), 1635.42 cm − 1  (C = O  stretching), 
and 1095.33 cm − 1 (C‑O stretching) was observed. The NMR analysis 
of M. marina KPMS1 chemical structure was predicted as 2‑(2E, 4E)‑3, 
7‑dimethylocta‑2,4‑dienyl)‑7‑hydroxy‑2,3,4,5‑tetrahydrobenzo[c] 
azepin‑1‑one. The molecular weight of compound was 313.43388 
and the molecular formula was C20H27NO2. The FT‑IR and NMR 
analysis was more or less similar trend which was observed with 
other researcher [24]. The active compounds derived from marine 
sediments showed a good actinobacterial activity and can be used as an 
industrially important one [25].
Phylogenetic relationship
The monitoring of different Micromonospora strains in species levels 
was done by molecular techniques. The genomic DNA was extracted 
from M. marina KPMS1 and amplified for 16 S rRNA gene using the 
primers F243 and R513GC [26]. The size of amplified 16S rRNA gene 
product of M. marina KPMS1 was approximately 900 bp. The samples 
were sequenced and compared for homology with other bacterial strain 
sequences deposited in the public databases using the National Center 
for Biotechnology Information BLAST function. The GenBank accession 
number of M. marina KPMS1 was MH036351.
The phylogenetic evolutionary analysis was performed in MEGA 
5.05 [27]. The sequence analysis usually includes alignment of sequences, 
construction of a phylogenetic tree, and testing the reliability of the 
constructed tree. The relationships of the aligned sequences are usually 
shown as a tree, in which the branching pattern of the tree displays the 
evolutionary relationships of the M. marina KPMS1. The most commonly 
applied tree construction method is distance method in which neighbour 
joining uses pair‑wise distances calculated from aligned sequences 
before correcting to evolutionary distances in a substitution model [28]. 
The shortest distant sequences were clustered together in a tree and its 
length was optimized to the correspondent distance matrix.
The phylogenetic tree of M. marina KPMS1 was constructed using 
16S rRNA gene sequence with that of other Micromonospora species. 
Fig. 1: Fourier‑transform infrared spectral analysis of Micromonospora marina KPMS1
Table 3: Preliminary screening of M. marina KPMS1 against 
multidrug‑resistant bacteria with standard drug
Samples E. coli P. aeruginosa E. faecalis
Cefotaxime 16 mm 17 mm 15 mm
KPMS 1 18±0.04 mm 17±0.01 mm 16±0.08 mm
Negative control 4 mm 4 mm 4 mm
RIZD (%) 88 76 80
M. marina: Micromonospora marina, E. coli: Escherichia coli, P. aeruginosa: 
Pseudomonas aeruginosa, E. faecalis: Enterococcus faecalis
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The optimal tree with the sum of branch length 1.15000000 was 
analyzed [Fig. 2]. The tree was drawn to scale, with branch lengths 
in the same units as those of the evolutionary distances used to infer 
the phylogenetic tree. The evolutionary distances were computed 
using p‑distance method and are in the units of the number of 
base substitutions per site. The phylogenetic tree showed two 
clades (I and II). The Clade I was subdivided into six smaller groups 
which encompass M. marina JSM1‑3, M. marina JSM1‑1, M. marina 
JSM3‑1, Micromonospora sp. 7K504, Micromonospora sp. CNH394, 
and Micromonospora sp. DS3001. The Clade II encompassed the strain 
M. marina KPMS1. This analysis involves eight nucleotide sequences. 
The codon positions included were 1st + 2nd + 3rd + noncoding. All 
positions containing gaps and missing data were eliminated. There 
were a total of 50 positions in the final dataset.
CONCLUSION
A genus Micromonospora are widely distributed in the marine 
environments and documented as a potential source of bioactive 
compounds. Among actinomycetes groups, Streptomyces sp. is 
considered as the dominant group found in the marine environment 
and also used for antibiotic research. Micromonospora is a rare group of 
actinomycetes which has been regarded as reservoir for antimicrobial 
agents. It had been emphasized that marine sediments might be 
valuable for the isolation of a novel strain of Micromonospora which 
potentially yield a broad spectrum of secondary metabolites. In reports 
suggested from the East Coast of India, soil is a major and suitable 
source of actinomycetes isolation. Correspondingly, the Kayalpatnam 
marine ecosystem is not only rich in biodiversity but also recognized 
a world heritage site and may provide the rich source for the discovery 
of Micromonospora sp. This study concludes that marine M. marina 
KPMS1 is well‑organized novel secondary metabolites synthesizer and 
holds potential for the treatment of clinical associated infection, acute 
lymphocytic leukemia, and cancer in other types. The screening of 
antimicrobial metabolite is a significant role toward the greater demand 
for new metabolites for the benefit of mankind and synthesized a lot of 
promising genera derived from marine sediment of Micromonospora sp. 
having medicinal importance in future.
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